Ocular Therapeutix
OCUL
#4790
Rank
NZ$3.83 B
Marketcap
NZ$17.45
Share price
-1.48%
Change (1 day)
-19.10%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -NZ$0.5 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are NZ$52.03 Million. In 2025 the company made an earning of -NZ$0.47 Billion a decrease over its 2024 earnings that were of -NZ$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.5 Billion6.9%
2025 -NZ$0.47 Billion37.43%
2024 -NZ$0.34 Billion139.68%
2023 -NZ$0.15 Billion13.65%
2022 -NZ$0.13 Billion984.05%
2021 -NZ$11.45 Million-95.79%
2020 -NZ$0.28 Billion80.19%
2019 -NZ$0.16 Billion44.01%
2018 -NZ$0.11 Billion-5.38%
2017 -NZ$0.12 Billion41.79%
2016 -NZ$78.1 Million12.47%
2015 -NZ$69.44 Million38.75%
2014 -NZ$50.05 Million115.12%
2013 -NZ$23.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-NZ$19.58 Million-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-NZ$21.41 Million-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-NZ$0.29 Billion-44.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
NZ$0.27 B-153.95%๐Ÿ‡บ๐Ÿ‡ธ USA